K08670369

Kromasil^® C8 HPLC Column

5 μm particle size, pore size 100 Å, L × I.D. 250 mm × 4.6 mm

• Sinónimos: C8 Reversed-Phase Chromatography Column
• UNSPSC Code: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Propiedades

• product line: Kromasil^®
• manufacturer/tradename: Kromasil^® KR100-5-C8-4.6X250
• availability: available only in USA, Canada and Puerto Rico; available only in USA, Canada and Puerto Rico
• technique(s): HPLC: suitable
• L × I.D.: 250 mm × 4.6 mm
• matrix active group: C8 (octyl) phase
• particle size: 5 μm
• pore size: 100 Å
• application(s): food and beverages
• separation technique: reversed phase

Descripción

Application

<ul>

<li><strong>Use of an UHPLC-MS/MS Method for Determination of Kuraridin and Characterization of Its Metabolites in Rat Plasma after Oral Administration.</strong>: This study developed and validated an ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for determining Kuraridin and its metabolites in rat plasma. A C18 guard cartridge was employed to enhance the method′s efficacy and precision, demonstrating the cartridge′s utility in complex biological sample analysis. (Liu et al., 2018).</li>

<li><strong>Rapid and economical high-performance liquid chromatographic method for the determination of norfloxacin in serum using a microparticulate C18 guard cartridge.</strong>: This paper presents a cost-effective high-performance liquid chromatography (HPLC) method utilizing a microparticulate C18 guard cartridge for the rapid determination of norfloxacin in serum. The study highlights the cartridge′s ability to maintain high sensitivity and specificity while reducing analysis time and cost. (Wallis et al., 1995).</li>

</ul>

Legal Information

Kromasil is a registered trademark of EKA Chemicals AB